Attention Deficit Hyperactivity Disorder Treatment

Some children are naturally calm, quiet, typically well-behaved, and delightful. Other children are the exact opposite and can be hyperactive troublemakers. They behave as if they are a tornado demolishing everything in their way. They run and jump all the time and it is impossible for them to sit still even for five minutes. They start to play games, build tents, and read books, but never seem to finish any of these activities. They would rather break toys as opposed to play with them; and, if you ask them to put toys away, they will, but then immediately take them out once more. All day long they are active and busy. Accordingly, if you recognize and are familiar with these types of behaviors in your child, then you may be interested in learning more about attention deficit hyperactivity disorder (ADHD).

Strattera from $0.83

If you are not able to properly identify ADHD symptoms when your child is young, unfortunately, as they grow up these symptoms can worsen. In the classroom setting, a child with ADHD can be at a serious disadvantage because it is very difficult for him/her to concentrate on learning activities.

Fortunately, ADHD symptoms may dissipate or lessen as a child grows up. Many individuals with ADHD are able to successfully adapt to everyday life. However, ADHD often times progresses and worsens with age. Individuals with ADHD may demonstrate constant procrastination, lack of organization, poor memory, and other undesired symptoms and habits. These ADHD related behaviors deteriorate the quality of life and interfere with a successful career. Unfortunately, ADHD is the most commonly occurring neurological and behavioral disease. Currently, it is estimated that ADHD is diagnosed in up to 5% of all children, most of whom are boys.

Developments in the pharmaceutical sciences have discovered a variety of medications that can be used to effectively deal with symptoms of ADHD such as impulsivity, inattention, and hyperactivity. Despite the availability of pharmacotherapies, not all medicine is effective and safe, particularly when treating young children.

Therefore, scientists have developed Strattera. The main active ingredient in Strattera is Atomoxetine, which is a highly selective inhibitor of presynaptic carriers of norepinephrine. This medication is not considered a stimulant or amphetamine derivative.

More than 5000 patients participated in clinical trials for Strattera. These careful and precise clinical trials have been conducted to observe and study effects associated with patients treated with Strattera. During clinical trials involving Strattera, no adverse reactions or adverse side effects were observed. Therefore, Strattera was approved and released to market.

 Currently, Strattera is used in 42 countries around the world. Official statistics approximate that more than 3.2 million children, teenagers, and adults diagnosed with ADHD have significantly improved their condition by taking this medication. Dosages of this drug should be individualized based patient condition. One box contains a blister pack of seven or fourteen pills accompanied by an instruction pamphlet. The therapeutic effects of this drug are known to occur shortly after taking a recommended dose.